Back to the Learning Academy.

Investor insights for issuers during a time of uncertainty (4-part series)

Given the recent market volatility and significant economic uncertainty, IHS Markit spoke with investors and analysts to assess how the current situation with COVID-19 is impacting their interactions with corporate issuers, in an effort to equip management and IR teams with real-time insights.

Related Articles

Beyond the Lab: Life Sciences Spotlight by TSX

Canada is home to a dynamic, fast-growing biotech, healthcare, and medical innovation industry, with companies driving breakthroughs that are transforming lives and shaping the future of healthcare. Yet for many investors, the life sciences sector can seem difficult to navigate, with technical language and complex science creating barriers to understanding its full potential.

From Booths to Breakouts: Reeling in Q2’s Top Conference Moments

The Company Services Team hit the ground running across a packed spring calendar, actively participating in and sponsoring premier conferences, roadshows, and industry events to connect our partners with vital capital and opportunity across the globe. We remained laser-focused on delivering high-impact visibility and fostering strategic connections, leveraging our sponsorship presence and active engagement to drive meaningful success for our network of issuers.